Structural and Functional Relationships in Glaucoma Using Standard Automated Perimetry and the Humphrey Matrix by Park, Seong Bae et al.
176
접수번호: 2008-106 Korean Journal of Ophthalmology 2009;23:176-182
ISSN : 1011-8942 
DOI : 10.3341/kjo.2009.23.3.176
Structural and Functional Relationships in Glaucoma Using 
Standard Automated Perimetry and the Humphrey Matrix
Seong Bae Park, MD
1, Yoon Pyo Nam, MD
2, Kyung Rim Sung, MD
2, Michael S. Kook, MD
2
1Department of Ophthalmology, University of Pochon, College of Medicine, CHA Medical Center, Bundang, Korea
2Department of Ophthalmology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea 
Purpose: To evaluate and compare correlations between structural and functional loss in glaucoma as assessed 
by optical coherence tomography (OCT), scanning laser polarimetry (GDx VCC, as this was the model used in this 
study), standard automated perimetry (SAP), and the Humphrey Matrix (Matrix).
Methods: Ninety glaucomatous eyes identified with SAP and 112 eyes diagnosed using Matrix were independently 
classified into six subgroups, either S1/M1 (MD>-6dB), S2/M2 (-12<MD<-6dB) or S3/M3 (MD<-12dB), according 
to the mean deviation (MD) of each test. Average and sectoral retinal nerve fiber layer (RNFL) thickness and per-
centage of abnormal classifications using the internal normative databases of OCT and GDx VCC were compared 
among the six subgroups.
Results: In the SAP subgroups, RNFL thickness values obtained by OCT in the nasal and temporal quadrants and 
the inferior averages of GDx VCC did not differ between the S1 and S2 subgroups (p=0.137, 0.738 and 0.149, 
respectively). In the Matrix subgroups, no measurement parameters differed between the M1 and M2 groups except 
for the overall mean and average inferior RNFL thickness given by OCT and the NFI values of GDx VCC (p=0.013, 
0.016 and 0.029, respectively). When abnormal classifications were compared, all measurement parameters, without 
exception, were significantly different in both the SAP and the Matrix subgroups. 
Conclusions: SAP subgroups showed a good correlation of structural and functional defects when assessed using 
OCT and GDx VCC. These correlations were weaker in the Matrix subgroups, especially in the early stages of glaucoma. 
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Glaucoma is a progressive optic neuropathy characterized 
by the loss of retinal ganglion cells (RGCs) and axons. These 
structural changes are known to presage functional deficits, 
causing gradual visual field (VF) defects.
1-2 Traditionally, glau-
comatous structural changes have been assessed by detailed 
ophthalmoscopic examination. Recently, objective and analytic 
approaches to structural assessment have become available 
with the development of imaging devices, most notably optical 
coherence tomography (OCT) and scanning laser polarimetry 
(SLP).
Standard automated perimetry (SAP) (Carl Zeiss Meditec 
Inc., Dublin, CA, USA) is the gold standard for testing func-
tional changes in glaucoma. This technique measures light sen-
sitivity thresholds at each retinal location. However, the method 
is not selective for the detection of particular glaucoma-related 
RGC damage. Therefore, VF defects may be detected by SAP 
only after the death of some RGCs.
3-4 
Humphrey Matrix Frequency doubling technology perimetry 
(Matrix) (Carl Zeiss Meditec Inc.) was developed to detect da-
mage to magnocellular ganglion cells, which are preferentially 
affected in glaucoma patients.
5 In this context, the Matrix has 
been found to be more sensitive than SAP because it can detect 
VF loss earlier.
6-9
Using a variable corneal compensator (VCC) (GDx VCC 
Carl Zeiss Meditec Inc.), a test of structural change, the GDx 
VCC can estimate the thickness of the retinal nerve fiber layer 
(RNFL) by measuring the summed retardation of a polarized 
scanning laser beam induced by form-birefringent microtubules 
supporting RGC axons.
10-13
Stratus OCT (Carl Zeiss Meditec Inc.) is used to obtain data 
on a cross-section of the retina based on the reflectivity of di-
fferent retinal layers; the technique can define the thickness 
of the circumpapillary RNFL.
14-16
Because the two imaging modalities use different techno-
logies to measure distinct aspects of retinal biology, it is po-
ssible that measurements derived from these approaches might 
show different associations with functional change.
In general, damage to the optic nerve and RNFL may precede 
VF loss in early glaucoma.
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including the Ocular Hypertension Treatment Study and the 
European Glaucoma Prevention Study, reported that the ear-
liest damage in glaucoma patients can be either structural or 
functional in nature.
17-18 Therefore, the relationship between 
functional and structural damage in glaucoma is a topic of 
debate.
The purpose of this study was to compare the structural 
changes in glaucoma assessed by OCT and GDx VCC and also 
the functional relationships detected by SAP and Matrix. We 
categorized patients into three groups according to the severity 
of their VF field injury, and evaluated the structural and func-
tional relationships using two different VF tests.
Materials and Methods
Participants
The medical records of all patients examined at the glaucoma 
clinic from January 2007 to March 2008 by one glaucoma spe-
cialist were reviewed, and if patients met the inclusion criteria 
of this study they were consecutively enrolled. All participants 
underwent a comprehensive ophthalmic examination, including 
visual acuity measurement, slit-lamp biomicroscopy, intraocular 
pressure measurement by Goldmann applanation tonometry, 
central corneal thickness ultrasound pachymetry measurement, 
SAP, Matrix, GDx VCC, and OCT. Patients were eligible if 
they had a best-corrected visual acuity greater than 20/40 and 
a normal anterior chamber and open-angle on slit-lamp and 
gonioscopic examinations, respectively. Participants with any 
other ophthalmic disease that could result in VF defects or who 
had histories of diabetes mellitus were excluded. A glaucoma-
tous optic disc was defined as a disc showing increased cupping 
(vertical cup-disc ratio >0.6), asymmetrical cupping (a between- 
eye difference in the vertical cup-disc ratio of >0.2), diffuse or 
focal neural rim thinning, hemorrhage, or nerve fiber layer de-
fects. Glaucomatous eyes defined by SAP (SAP group) were 
those with a glaucomatous optic disc appearance and glauco-
matous VF defects defined by the glaucoma hemifield test 
(GHT) as outside 99% of age-specific normal limits and also 
with a pattern standard deviation (PSD) outside 95% of the 
normal limit with the 24-2 full threshold program or the 24-2 
Swedish Interactive Threshold Algorithm (SITA) standard 
programs of the HFA.
The same VF criteria were used to define glaucomatous eyes 
identified by Matrix. Eyes with a glaucomatous optic disc appea-
rance and a GHT result outside 99% of the age-specific normal 
limits with a PSD outside 95% of the normal limit with Matrix 
were categorized by Matrix as suffering from glaucoma (Matrix 
group). Since there were no generalized criteria in Matrix for 
diagnosing glaucoma, we arbitrarily applied the same criteria 
as in SAP to the Matrix results.
We included only those patients who, within one month of 
the initial evaluation, yielded a reliable VF measurement, de-
fined as a false-positive error <15%, a false-negative error < 
15% and a fixation loss <20% in both SAP and Matrix. One eye 
was randomly selected if both eyes were found to be eligible. 
Subsequently, 90 eyes were classified as glaucomatous in the 
SAP group and 112 eyes were identified in the Matrix group. 
All procedures conformed to the Declaration of Helsinki, and 
the study was approved by the Ethics Committee of the Asan 
medical center. Written informed consent was obtained from 
all patients.
Optical Coherence Tomography (Stratus OCT)
OCT measures RNFL thickness with a low-coherence light 
source projected onto the retina. The time delay of the light 
backscatter from the RNFL compared with light reflected by 
a reference mirror is then calculated. Circumpapillary RNFL 
was measured in the fast RNFL mode using three 360-degree 
circular, high-resolution scans with a diameter of 3.4 mm that 
were centered on the optic disc. RNFL thicknesses of the collec-
tive quadrants (360° measure), as well as the individual tem-
poral (316°-45°), superior (46°-135°), nasal (136°-225°), and 
inferior (226°-315°) quadrants, were obtained for analysis. Dia-
gnostic categorization by Stratus OCT involves a software- 
based comparison of thickness parameters with an internal 
normative database of 328 eyes; we also evaluated these pa-
rameters in our study. Parameters on the Stratus OCT printout 
are annotated to indicate whether they fall outside of the 99% 
confidence interval (CI), between the 95% and 99% CIs (bor-
derline) or within the 95% CI (normal). In this study, only well- 
focused and centered scans with signal strengths ≥ seven were 
included, and a parameter was considered outside the normal 
limits if CI < 95% and within the normal limits if CI > 95%.
Scanning Laser Polarimetry (SLP) 
SLP imaging was performed in a standardized fashion (GDx 
VCC software version 5.5.0) with a circular scan (3.2 mm in 
diameter) centered on the optic disc. The general principles of 
SLP with variable corneal polarization compensation (VCC) 
have been described in detail elsewhere.
19-21 We only analyzed 
eyes with a scan quality score of eight or better. Images with 
atypical retardation patterns (ARPs) were excluded from the 
study. The SLP parameters examined were TSNIT (temporal, 
superior, nasal, inferior, and temporal) imaging, superior ima-
ging, inferior average imaging, and the nerve fiber indicator 
(NFI). The GDx VCC printout provides probabilities of ab-
normality based on a comparison with an internal database 
containing information on 540 normal eyes. In this study, a 
parameter was considered outside the normal limits if p<0.05 
and within the normal limits if p>0.05. For the NFI parameter, 
the manufacturer-suggested cutoff of < 30 was considered as 
within the normal limits, whereas values of 31-100 were con-
sidered abnormal.
Study Group
Participants were classified based on the severity of their Korean J Ophthalmol Vol.23, No.3, 2009
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Fig. 1. Overview of the division of the SAP and Matrix groups and Analyses 1 and 2.
Table 1. Patient Characteristics
SAP group (n=90) Matrix group (n=112) p-value
Age (years) (mean±SD) 56.9±13.4 54.4±12.6 0.674
Sex
 Male (n and %) 45 (50.0%) 57 (50.9%)
 Female (n and %) 45 (50.0%) 55 (49.1%)
Refraction (D) (Mean±SD) -0.56±2.04 -0.69±1.91 0.527
MD (Mean±SD) -7.63±6.17 -8.10±5.90 0.872
PSD (Mean±SD) 6.97±4.26 5.22±1.88 0.000
*
Vision (Log mar scale) -0.82±0.17 -0.82±1.6 0.831
Tested eye
 Right (n and %) 52 (57.8%) 73 (65.2%)
 Left (n and %) 38 (42.2%) 39 (34.8%)
Type of glaucoma
 POAG (n and %) 17 (18.9%) 19 (17.0%)
 NTG (n and %) 65 (72.2%) 82 (73.2%)
 SOAG (n and %) 5 (5.6%) 6 (5.4%)
 PACG (n and %) 3 (3.3%) 5 (4.4%)
D=diopters; SAP=standard automated perimetry; Matrix=frequency doubling technology perimetry 24-2 performed with the Humphrey 
Matrix; SD=standard deviation; MD=mean deviation;PSD=pattern standard deviation; SAP group=laucoma group diagnosed by standard 
automated perimetry; Matrix group=laucoma group diagnosed by Humphrey Matrix perimetry; POAG=rimary open angle glaucoma; NTG= 
normal tension glaucoma; SOAG=econdary open angle glaucoma; PACG=rimary angle closure glaucoma.
* statistically significant (p<0.05).
functional damage as assessed by SAP and Matrix. Since no 
generalized criteria for categorizing glaucoma severity using 
Matrix exists, we used the same mean deviation (MD) values 
for both SAP and Matrix. With reference to the mean deviations 
of SAP and Matrix, each VF defect was classified as early (no 
worse than -6dB): groups S1 and M1; moderate (worse than -6 
dB but not worse than -12dB): groups S2 and M2; and advanced 
(worse than -12dB): groups S3 and M3.
22  The S1, S2 and S3 
subgroups were classified according to SAP severity, whereas 
subgroups M1, M2 and M3 were determined by Matrix severity 
scores.
Data analysis
All statistical tests were performed using a statistical soft-
ware package (SPSS 15.0 for Windows; SPSS Inc., Chicago, 
IL). RNFL thicknesses measured by OCT and GDx VCC were 
compared among the three groups categorized by MD scores 
from both SAP and Matrix using a one-way analysis of variance 
(ANOVA) with pairwise, post-hoc Tukey comparisons. The 
normative classifications determined by the internal databases 
of the OCT and GDx VCC instruments were compared among 
the three subgroups for each of SAP and Matrix using the Chi- 
square test. Differences with a value of p<0.05 were considered 
statistically significant (Fig.1).
Results 
The mean age of the 90 participants in the SAP group was 
56.9±13.4 years, and the mean age of the 112 participants in SB Park, et al. FUNCTIONAL AND STRUCTURAL DAMAGE IN GLAUCOMA SUBGROUPS
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Table 2. Subgroups divided by mean deviations of SAP and Matrix
Grade
SAP group Matrix group
Subgroup No. MD 
(Mean±SD)
PSD




Early (-6dB<MD) S1 21  -1.43±1.04 2.78±0.79 M1 47 -2.65±2.00 4.19±1.28
Moderate (-12dB<MD<-6dB) S2 50 -6.51±2.59 6.69±3.45 M2 39 -8.53±1.67 5.38±1.67
Severe (MD<-12dB) S3 19 -17.41±4.41 12.34±2.38 M3 26 -16.8±3.21 9.36±3.53
MD=mean deviation; PSD=pattern standard deviation; No.=number of patients; SAP group: glaucoma group diagnosed using standard 
automated perimetry; S1, S2, S3=subgroups divided by mean deviation of standard automated perimetry; Matrix group=glaucoma group 
diagnosed using Humphrey Matrix perimetry; M1, M2, M3=subgroups divided by mean deviation of Humphrey Matrix perimetry.
Table 3. Comparison of OCT and GDx VCC parameters between the SAP group and the Matrix group 
Instrument  Parameter  SAP group Matrix group p-value
Stratus OCT Superior thickness 94.64±28.66 104.21±27.61 0.402
Nasal thickness 64.79±17.81 68.42±18.44 0.764
Inferior thickness 94.04±32.87 106.09±31.45 0.378
Temporal thickness 61.97±19.64 65.18±18.08 0.438
Average thickness 79.66±19.58 86.77±18.55 0.409
GDx VCC TSNIT average 41.36±8.19 43.91±7.94 0.634
Superior average 48.76±11.36 52.35±10.97 0.675
Inferior average 44.23±11.25 47.88±11.50 0.894
TSNIT SD 14.40±4.95 15.86±5.10 0.833
NFI 54.91±23.26 46.04±22.37 0.673
NFI=nerve fiber indicator; SAP group=glaucoma group diagnosed using standard automated perimetry; Matrix group=glaucoma group 
diagnosed using Humphrey Matrix perimetry; TSNIT=temporal-superior-nasal-inferior-temporal; SD=standard deviation.
Table 4. Analysis 1: Comparison of RNFL thickness between each subgroup classified by SAP (S1, S2 and S3) and 
Matrix (M1, M2 and M3)
Instrument Parameter 
SAP group Matrix group
S1-S2 S1-S3 S2-S3 M1-M2 M1-M3 M2-M3




























































SAP group: glaucoma group diagnosed using standard automated perimetry; S1, S2, S3=subgroups divided according to the mean deviation 
of standard automated perimetry; Matrix group=glaucoma group diagnosed using Humphrey Matrix perimetry; M1, M2, M3=subgroups 
divided according to the mean deviation of Humphrey Matrix perimetry; NFI=nerve fiber indicator; TSNIT=temporal-superior-nasal-inferior- 
temporal; SD=standard deviation; All data were analyzed by ANOVA (post-hoc comparison).
* statistically significant (p<0.05).
the Matrix group was 54.4±12.6 years. Table 1 summarizes the 
demographics and clinical characteristics of both groups. In 
the SAP group, 21 eyes were classified as S1, 50 eyes as S2, 
and 19 as S3, according to MD criteria. In the Matrix group, 
47 eyes were classified as M1, 39 eyes as M2, and 26 eyes as 
M3 (Table 2). 
Analysis 1: SAP subgroups vs. Matrix subgroups with reference 
to RNFL thicknesses assessed by OCT and GDx VCC
Structural parameters assessed by OCT and GDx VCC were 
compared in the SAP subgroups and the Matrix subgroups (Table 
3). Average RNFL thickness measured by OCT was 79.7±19.5 
μm in the SAP group and 86.8±18.6 μm in the Matrix group (p= 
0.41). The average NFI determined by GDx VCC was 54.9± 
23.3 in the SAP group and 46.0±22.4 in the Matrix group (p= Korean J Ophthalmol Vol.23, No.3, 2009
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Table 5. Comparison of observed parameters with data in internal normative databases between each subgroup 
classified by SAP (S1, S2 and S3) and Matrix (M1, M2 and M3)
Instrument Parameter 




group S1 (n=21) S2 (n=50) S3 (n=19) M1 (n=47) M2 (n=39) M3 (n=26)
Stratus OCT Superior thickness 0.001
* <0.001
* 3 (14.3%) 25 (50.0%) 15 (78.9%) 8 (17.0%) 11 (28.2%) 38 (33.9%)
Nasal thickness 0.026
* 0.007
* 1 (4.8%) 12 (24.0%) 6 (31.6%) 4 (8.5%) 4 (10.3%) 10 (38.5%)
Inferior thickness <0.001
* <0.001
* 3 (14.3%) 23 (46.0%) 18 (94.7%) 7 (14.9%) 12 (30.8%) 19 (73.1%)
Temporal thickness <0.001
* <0.001
* 1 (4.8%) 11 (22.0%) 12 (63.2%) 4 (8.5%) 4 (10.3%) 10 (38.5%)
Average thickness <0.001
* <0.001
* 3 (14.3%) 21 (42.0%) 18 (94.7%) 7 (14.9%) 8 (20.6%) 20 (76.9%)
GDx VCC TSNIT average 0.003
* 0.001
* 12 (57.1%) 36 (72.0%) 17 (89.5%) 22 (46.8%) 26 (66.7%) 22 (84.6%)
Superior average 0.030
* 0.001
* 12 (57.1%) 35 (70.0%) 19 (100.0%) 21 (44.7%) 23 (59.0%) 24 (92.3%)
Inferior average 0.002
* 0.013
* 10 (47.6%) 33 (66.0%) 17 (89.5%) 21 (44.7%) 22 (56.4%) 20 (76.9%)
TSNIT SD 0.006
* 0.014
* 8 (38.1%) 23 (46.0%) 16 (84.2%) 18 (38.3%) 13 (33.3%) 18 (69.1%)
NFI (>30) 0.013
* 0.004
* 13 (61.9%) 39 (78.0%) 19 (100%) 24(51.1%) 28 (71.8%) 23 (88.5%)
SAP group=glaucoma group diagnosed using standard automated perimetry; S1, S2, S3=subgroups divided by mean deviation of standard 
automated perimetry; Matrix group=glaucoma group diagnosed using Humphrey Matrix perimetry; M1, M2, M3=subgroups divided by mean 
deviation of Humphrey Matrix perimetry; NFI=nerve fiber indicator; TSNIT=temporal-superior-nasal-inferior-temporal; SD=standard deviation; 
All data were analyzed using the Chi-square test. 
* statistically significant (p<0.05).
0.67). Overall, no RNFL thickness parameter measured using 
either OCT or GDx VCC differed, with statistical significance, 
between the SAP and Matrix groups. 
In the SAP group, average, superior and inferior RNFL thic-
knesses measured by OCT were significantly different between 
the S1 and S2 groups (p=0.001, 0.011 and 0.000, respectively), 
whereas the average and inferior RNFL thicknesses were sig-
nificantly different in the M1 and M2 groups (p=0.016 and 0.013, 
respectively). Nasal and temporal RNFL thicknesses did not 
differ when the S1 and S2 or the M1 and M2 subgroups were 
compared. TSNIT values, superior averages, TSNIT SDs, and 
NFIs assessed by GDx VCC were significantly different bet-
ween the S1 and S2 subgroups, but only NFIs were signifi-
cantly different between the M1 and M2 subgroups. All para-
meters of OCT and GDx VCC were significantly different bet-
ween the S2 and S3 subgroups and also between the S1 and 
S3 subgroups. Matrix subgroup analysis also revealed signi-
ficant differences between groups M2 and M3, and M1 and 
M3 (Table 4).
Analysis 2: SAP group vs. Matrix group with reference to 
normative classifications assessed by OCT and GDx VCC 
We used the Chi-square test to compare structural parameters 
interpreted with the internal normative databases. Compared to 
abnormal classifications, percentages of such classifications 
among the subgroups were significantly different in all para-
meters in both the SAP and Matrix subgroups (Table 5).
Discussion
SAP is considered to be a standard approach for detecting 
VF loss in glaucoma.
1 However, SAP may not be able to detect 
early functional changes because of redundancies in RGCs 
and optic nerve fibers, which can mask damage.
23,24
As a screening device, Humphrey Matrix Frequency dou-
bling technology perimetry (Matrix) is known to be similar to 
or better than the Humphrey field analyzer.
25-28 Frequency dou-
bling technology (FDT) perimetry was developed as a method 
to detect early glaucoma by attempting to functionally isolate 
“My” cells, which may be selectively damaged in the early 
stages of glaucoma.
1,25,29 My cells are not functionally redundant 
(making up 3-5% of all ganglion cells); the FDT technique 
thus has the theoretical potential to identify early VF loss.
30,31 
Matrix perimetry is an updated version of FDT perimetry, 
employing a larger number of stimulus locations and smaller 
targets than those used in FDT perimetry. Matrix also provides 
the global indices of SAP, such as MD, PSD and GHT classi-
fication, in a standard printout.
32-35 Comparison of Matrix and 
SAP threshold sensitivities is not appropriate because the two 
technologies measure different aspects of retinal sensitivity 
SAP assesses differential light sensitivity, and Matrix obtains 
data on contrast sensitivity. Although global indices were re-
ported to be significantly correlated between SAP and Matrix,
36,37 
there is no consensus for the definition of glaucomatous VF 
defects as determined by Matrix. Therefore, we used the same 
criteria (PSD < 5% and abnormal GHT) to define glaucoma 
identified by both SAP and Matrix, and we divided patients 
into three groups according to the severity of the MD. 
Stratus OCT and GDx VCC are the two most recent com-
mercial instruments available to analyze peripapillary RNFL 
thickness. In many studies, both GDx VCC and OCT showed 
relatively high diagnostic accuracies in glaucoma detection.
38-41 
Average RNFL thickness by OCT demonstrated a strong corre-
lation with VF defects.
42 The NFI data from GDx VCC also 
revealed a strong correlation with VF defects. However, RNFL 
thicknesses determined by OCT in the nasal and temporal qua-




Reus and Lemij suggested that glaucoma patients with mild- 
to-moderate VF loss might be better monitored with the GDx 
VCC.
47 Kim and Kook reported that abnormal scores obtained 
on FDT perimetry screening programs correlated negatively 
with RNFL retardation values, as measured in glaucomatous 
changes seen by SLP.
48 However, to our knowledge, no data 
confirming a relationship between VF loss and GDx and OCT 
Matrix data has been published.
In this study, we divided patients into subgroups using MD 
values from both SAP and Matrix. Our results showed that all 
structural parameters except nasal and temporal RNFL thick-
nesses obtained by OCT were significantly different among 
cases in the three different stages of glaucoma. These findings 
suggest good correlations between RNFL thickness parame-
ters assessed by OCT and GDx VCC on the one hand, and SAP 
defects on the other, in patients in different stages of glaucoma. 
Only nasal and temporal quadrant data of OCT, and the infe-
rior average of GDx VCC, showed no meaningful correlations 
between early (S1) and moderate (S2) glaucoma stages as asse-
ssed by SAP. This might be explained by high measurement 
variability.
43-45 The fact that nasal and temporal quadrants are 
relatively more resistant to glaucomatous damage may also 
partly explain these findings. 
However, not all structural parameters showed significant 
differences between early (M1) and moderate (M2) stages of 
glaucoma as assessed by Matrix. Average and inferior RNFL 
thicknesses by OCT and NFI by GDx VCC were significantly 
different between the M1 and M2 subgroups, but there were 
no differences in any other parameters. Although some para-
meters did not differ between the M1 and M2 subgroups, all 
parameters assessed by GDx VCC and OCT showed signifi-
cant differences between the moderate (subgroup M2) and ad-
vanced (subgroup M3) patients. 
Matrix is known to be superior to SAP for detecting the early 
stages of glaucoma. In this study, we observed that although 
the Matrix subgroups showed definite structural differences 
between cases of moderate and severe glaucoma as assessed 
by GDx and OCT parameters, not all parameters differed bet-
ween patients with early and moderate glaucoma. This could 
indicate that Matrix can be an excellent screening device to 
detect early glaucoma, especially in the preperimetric stage, 
but it has difficulty in discriminating between the early and 
moderate stages of glaucoma. The other possible explanation 
for the poor correlation of structural damage with functional 
deficits as determined by Matrix in early-to-moderate glau-
coma stages is related to the reliability of Matrix itself. Most 
enrolled participants were tested only once for each Matrix 
and SAP. The learning effect of Matrix may improve VF out-
come in repeat tests. We acknowledge that this is a limitation 
of our study. Because the study design was retrospective, all 
participants underwent a comprehensive ophthalmic exami-
nation at the initial visit, including SAP, FDT, OCT, and GDx 
VCC. If reliability indices were poor during testing, the operator 
stopped the test, explained the process thoroughly, and then 
restarted the test. To maximize reliability and to minimize lear-
ning effect-related issues, we adopted strict VF inclusion criteria.  
To our knowledge, this is the first study to examine the re-
lationship between functional and structural damage in glau-
coma subgroups of different severities using both SAP and 
Matrix global indices. We concluded that glaucoma status as 
defined by both SAP and Matrix correlates with structural loss 
as assessed by OCT and GDx VCC, but that such correlations 
are slightly weaker in the early-to-moderate glaucoma stages 
as defined by Matrix. 
References
  1. Kerrgan-Baumrind LA, Quigley HA, Pease ME, et al. Number of 
ganglion cells in glaucoma eyes compared with threshold visual 
field tests in the same persons. Invest Ophthalmol Vis Sci 2000; 
41:741-8.
  2. Quigley HA, Addicks EM, Green WR. Optic nerve damage in hu-
man glaucoma. III. Quantitative correlation of nerve fiber loss and 
visual field defect in glaucoma, ischemic neuropathy, papille-
dema, and toxic neuropathy. Arch Ophthalmol 1982;100:135-46.
  3. Quigley HA, Dunkelberger GR, Green WR. Retinal ganglion cell 
atrophy correlated with automated perimetry in human eyes with 
glaucoma. Am J Ophthalmol 1989;107:453-64.
  4. Harwerth RS, Quigley HA. Visual field defects and retinal gang-
lion cell losses in patients with glaucoma. Arch Ophthalmol 2006; 
124:853-59.
  5. Maddess T, Goldberg I, Dobinson J, et al. Testing for glaucoma with 
the spatial frequency doubling illusion. Vision Res 1999; 39:4258- 
73.
  6. Soliman MA, de Jong LA, Ismaeil AA, et al. Standard achromatic 
perimetry, short wavelength automated perimetry, and frequency 
doubling technology for detection of glaucoma damage. Oph-
thalmology 2002;109:444-54.
  7. Kogure S, Toda Y, Tsukahara S. Prediction of future scotoma on 
conventional automated static perimetry using frequency doubling 
technology perimetry. Br J Ophthalmol 2006;90:347-52.
  8. Medeiros FA, Sample PA, Weinreb RN. Frequency doubling te-
chnology perimetry abnormalities as predictors of glaucomatous 
visual field loss. Am J Ophthalmol 2004;137:863-71.
  9. Kamantigue MEG, Joson PJ, Chen PP. Prediction of visual field 
defects on standard automated perimetry by screening C-20-1 
frequency doubling technology perimetry. J Glaucoma 2006;15: 
35-9.
10. Huang XR, Knighton RW. Linear birefringence of the retinal nerve 
fiber layer measured in vitro with a multispectral imaging mic-
ropolarimeter. J Biomed Opt 2002;7:199-204.
11. Dreher AW, Bailey ED. Assessment of the retinal nerve fiber layer 
by scanning-laser polarimetry. SPIE 1993;1877:266-71.
12. Zangwill LM, Medeiros FA, Bowd C, Weinreb RN. Optic nerve 
imaging: recent advances. In: Grehn F, Stamper R, eds. Glaucoma, 
Vol.2. Berlin: Springer Verlag; 2004;63-91.
13. Reus NJ, Colen TP, Jemij HG. Visualization of localized retinal 
nerve fiber layer defects with the GDx with individualized and 
with fixed compensation of anterior segment birefringence. Oph-
thalmology 2003;110:1512-6.
14. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomogra-
phy. Science 1991;254:1178-81.
15. Izatt JA, Hee MR, Swanson EA, et al. Micrometer-scale resolution 
imaging of the anterior eye in vivo with optical coherence tomo-
graphy. Arch Ophthalmol 1994;112:1584-9.
16. Schuman JS, Hee MR, Puliafito CA, et al. Quantification of nerve 
fiber layer thickness in normal and glaucomatous eyes using op-
tical coherence tomography. Arch Ophthalmol 1995;113:586-96.Korean J Ophthalmol Vol.23, No.3, 2009
182
17. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hyper-
tension Treatment Study: a randomized trial determines that topical 
ocular hypotensive medication delays or prevents the onset of pri-
mary open-angle glaucoma. Arch Ophthalmol 2002;120:701-13.
18. European Glaucoma Prevention Study (EGPS) Group. Results of 
the European Glaucoma Prevention Study. Ophthalmology 2005; 
112:366-75.
19. Zhou Q, Weinreb RN. Individualized compensation of anterior 
segment birefringence during scanning laser polarimetry. Invest 
Ophthalmol Vis Sci 2002;43:2221-8.
20. Weinreb RN, Bowd C, Zangwill LM. Glaucoma detection using 
scanning laser polarimetry with variable corneal polarization com-
pensation. Arch Ophthalmol 2003;121:218-24.
21. Hodapp E, Parrish RK, Anderson DR. Clinical decisions in glau-
coma, Vol.1. St. Louis: Mosby, 1993;52-63.
22. Beck RW, Bergstrom TJ, Lichter PR. A clinical comparison of 
visual field testing with a new automated perimeter, the Hum-
phrey Field Analyzer and the Goldmann perimeter. Ophthalmo-
logy 1985;92:77-82.
23. Sample PA, Bosworth CF, Blumenthal EZ, et al. Visual function-
specificperimetry for indirect comparison of different ganglioncell 
populations in glaucoma. Invest Ophthalmol Vis Sci 2000;41: 
1783-90.
24. Harwerth R, Carter-Dawson L, Shen F, et al. Ganglion cell losses 
underlying visual field defects from experimental glaucoma. Invest 
Ophthalmol Vis Sci 1999;40:2242-50.
25. White AJ, Sun H, Swanson WH, Lee BB. An examination of phy-
siological mechanisms underlying the frequency-doubling illusion. 
Invest Ophthalmol Vis Sci 2002;43:3590-9.
26. Cello KE, Nelson-Quigg JM, Johnson CA. Frequency doubling 
technology perimetry for detection of glaucomatous visual field 
loss. Am J Ophthalmol 2000;129:314-22.
27. Johnson CA, Samuels SJ. Screening for glaucomatous visual field 
loss with frequency-doubling perimetry. Invest Ophthalmol Vis 
Sci 1997;38:413-25.
28. Quigley HA. Identification of glaucoma-related visual field ab-
normality with the screening protocol of frequency doubling te-
chnology. Am J Ophthalmol 1998;125:819-29.
29. Maddess T, Henry GH. Performance of nonlinear visual units in 
ocular hypertension and glaucoma. Clin Vis Sci 1992;7:371-83.
30. Brusini P, Busatto P. Frequency doubling perimetry in glaucoma 
early diagnosis. Acta Ophthalmol Scand 1998;76(S227):23-4.
31. Burnstein Y, Ellish NJ, Magbalon M, et al. Comparison of frequen-
cy doubling perimetry with Humphrey visual field analysis in a 
glaucoma practice. Am J Ophthalmol 2000;129:328-33.
32. Johnson CA, Samuels JS. Screening for glaucomatous visual field 
loss with frequency-doubling perimetry. Invest Ophthalmol Vis 
Sci 1997;38:413-25.
33. Patel SC, Friedman DS, Varadkar P, et al. Algorithm for interp-
reting the results of frequency doubling perimetry. Am J Ophthal-
mol 2000;129:323-7.
34. Sample PA, Medeiros FA, Racette L, et al. Identifying glaucoma-
tous vision loss with visual-function-specific perimetry in the dia
gnostic innovations in glaucoma study. Invest Ophthalmol Vis 
Sci 2006;47:3381-9.
35. Paczka JA, Friedman DS, QuigleyHA, et al. Diagnostic capabili-
ties of frequency doubling technology, scanning laser polarimetry 
and nerve fiber layer photographs to distinguish glaucomatous da-
mage. Am J Ophthalmol 2001;131:188-97.
36. Serguhn S, Spiegel D. Comparison of frequency doubling peri-
metry and standard achromatic computerized perimetry in pa-
tients with glaucoma. Graefes Arch Clin Exp Ophthalmol 2001; 
239:351-5.
37. Fukushima A, Shirakashi M, Yaoeda K, et al. Relationship between 
indices of Humphrey perimetry and frequency doubling techno-
logy perimetry in glaucoma. J Glaucoma 2004;13:114-9.
38. Sponsel WE, Arango S, Trigo Y, et al. Clinical classification of 
glaucomatous visual field loss by frequency doubling perimetry. 
Am J Ophthalmol 1998;125:830-6.
39. Medeiros FA, ZangwillLM, Bowed C, et al. Fourier analysis of 
scanning laser polarimetry measurements with variable corneal 
compensation in glaucoma. Invest Ophthalmol Vis Sci 2003;44: 
2606-12.
40. Medeiros FA, Zangwill LM, Bowed C, et al. Evaluation of retinal 
nerve fiber layer, optic nerve head, and macular thickness mea-
surements for glaucoma detection using optical coherence to-
mopraphy. Am J Ophthalmol 2005;139:44-55.
41. Budenz DL, Michael A, Chang RT, et al. Sensitivity and specificity 
of the Stratus OCT for perimetric glaucoma. Ophthalmology 2005; 
112:3-9.
42. Bagga H, Greenfield DS, Feuer W, et al. Scanning Laser Polari-
metry With Variable Corneal Compensation and Optical Coherence 
Tomography in Normal and Glaucomatous Eyes. Am J Ophthal-
mol 2003;135:521-9.
43. Kanamori A, Nakamura M, Escano MFT, et al. Evaluation of the 
Glaucomatous Damage on Retinal nerve fiber layer thickness 
measured by Optical Coherence Tomography. Am J Ophthalmol 
2003;135:513-20.
44. Blumenthal EZ, Williams JM, Weinreb RN, et al. Reproducibility 
of nerve fiber layer thickness measurements by use of optical 
coherence tomography. Ophthalmology 2000;107:2278-82.
45. Carpineto P, Ciancaglini M, Zuppardi E, et al. Reliability of nerve 
fiber layer thickness measurements using optical coherence to-
mography in normal and glaucomatous eyes. Ophthalmology 2003; 
110:190-5.
46. Kook MS, Sung K, Park RH, et al. Reproducibility of scanning 
laser polarimetry (GDx) of peripapillary retinal nerve fiber layer 
thickness in normal subjects. Graefes Arch Clin Exp Ophthalmol 
2001;239:118-21.
47. Reus NJ, Nemij HG. The relationship between standard automated 
perimetry and GDx VCC measurements. Invest Ophthalmol Vis 
Sci 2004;45:840-5.
48. Kim SH, Yang SJ, Kook MS, et al. Correlation Between Frequency 
Doubling Technology Perimetry and Scanning Laser Polarimetry 
in Glaucoma Suspects and Glaucomatous Eyes. Korean J oph-
thalmol 2004;18:89-99.